GSK plc

GSK ORD GBP0.3125
Create an alert
Sell1,816.00p
Buy1,817.00p
40.00p (2.15%)
Last updated today at
Back to dashboard

Director deals

Listed below are trades carried out by directors and other individuals which are required to be notified to the market.

Recent deals

DateName and position (if held)Deal typeNumber of
shares dealt
Price per
share
Value of
trade
Shares
remaining
11 August 2026
Lynn BaxterOther President
Buy
Regular purchase transaction
7£19.35£135.450
11 August 2026
James Robert Anthony FordGeneral Counsel
Buy
Regular purchase transaction
7£19.35£135.450
11 August 2026
Lynn BaxterOther President
Buy
Regular purchase transaction
7£19.35£135.450
11 August 2026
Regis SimardOther President
Buy
Regular purchase transaction
7£19.35£135.450
11 August 2026
Philip C (Phil) ThomsonOther President
Buy
Regular purchase transaction
7£19.35£135.450
11 August 2026
Deborah Jayne WaterhouseOther CEO
Buy
Regular purchase transaction
7£19.35£135.450
11 August 2026
David Simon RedfernOther President
Buy
Regular purchase transaction
7£19.35£135.450
11 August 2026
Julie Belita BrownCFO
Buy
Regular purchase transaction
7£19.35£135.45297,199
11 August 2026
Victoria Anne WhyteCompany Secretary
Buy
Regular purchase transaction
6£19.35£116.10182,990
7 August 2026
Maya Martinez-DavisOther President
Buy
Regular purchase transaction
9$52.96$476.640

5 most significant deals

DateName and position (if held)Deal typeNumber of
shares dealt
Price per
share
Value of
trade
Shares
remaining
5 February 2026
Hal V. BarronNon-Executive Director
Sell
Regular sell transaction (market)
67,602$59.17$4,000,010.34549,094
13 February 2026
Tony WoodChief Level Officer
Sell
Tax related
103,330£21.60£2,231,948.670
5 February 2026
David Simon RedfernOther President
Sell
Option/Award related
100,000£21.09£2,109,000.000
29 October 2025
Deborah Jayne WaterhouseOther CEO
Sell
Regular sell transaction (market)
120,000£16.89£2,026,380.000
13 February 2026
Shobie RamakrishnanCTO
Sell
Tax related
30,806$58.85$1,812,960.830

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Director deal information provided by Factset.